Found: 78
Select item for more details and to access through your institution.
Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 5, p. 848, doi. 10.1007/s10637-018-0562-4
- By:
- Publication type:
- Article
Active Transport of Uric Acid Through the Human Erythrocyte Membrane.
- Published in:
- Nature, 1959, v. 184, n. 4685, p. 553, doi. 10.1038/184553b0
- By:
- Publication type:
- Article
Capture and Detection of Circulating Glioma Cells Using the Recombinant VAR2CSA Malaria Protein.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 9, p. 998, doi. 10.3390/cells8090998
- By:
- Publication type:
- Article
Immune Cell Profiling of Peripheral Blood as Signature for Response During Checkpoint Inhibition Across Cancer Types.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.558248
- By:
- Publication type:
- Article
Neoepitope load, T cell signatures and PD-L2 as combined biomarker strategy for response to checkpoint inhibition immunotherapy.
- Published in:
- Frontiers in Genetics, 2023, v. 14, p. 1, doi. 10.3389/fgene.2023.1058605
- By:
- Publication type:
- Article
Detecting and Targeting NTRK Fusions in Cancer in the Era of Tumor Agnostic Oncology.
- Published in:
- Drugs, 2021, v. 81, n. 4, p. 445, doi. 10.1007/s40265-020-01459-w
- By:
- Publication type:
- Article
Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-00450-6
- By:
- Publication type:
- Article
'Plumb line scribe': Using multimedia to preserve traditional craft skills.
- Published in:
- Craft Research, 2013, v. 4, n. 1, p. 31, doi. 10.1386/crre.4.1.31_1
- By:
- Publication type:
- Article
Changes in key recruitment performance metrics from 2008–2019 in industry-sponsored phase III clinical trials registered at ClinicalTrials.gov.
- Published in:
- PLoS ONE, 2022, v. 17, n. 7, p. 1, doi. 10.1371/journal.pone.0271819
- By:
- Publication type:
- Article
ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling – a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10632-9
- By:
- Publication type:
- Article
Sorafenib in Advanced Hepatocellular Carcinoma: A Nationwide Retrospective Study of Efficacy and Tolerability.
- Published in:
- Scientific World Journal, 2013, p. 1, doi. 10.1155/2013/931972
- By:
- Publication type:
- Article
Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 137, n. 3, p. 533, doi. 10.1007/s11060-017-2739-7
- By:
- Publication type:
- Article
Phase II open-label study of nintedanib in patients with recurrent glioblastoma multiforme.
- Published in:
- Journal of Neuro-Oncology, 2013, v. 111, n. 2, p. 205, doi. 10.1007/s11060-012-1009-y
- By:
- Publication type:
- Article
Modeling Metastatic Colonization in a Decellularized Organ Scaffold‐Based Perfusion Bioreactor (Adv. Healthcare Mater. 1/2022).
- Published in:
- Advanced Healthcare Materials, 2022, v. 11, n. 1, p. 1, doi. 10.1002/adhm.202270001
- By:
- Publication type:
- Article
Modeling Metastatic Colonization in a Decellularized Organ Scaffold‐Based Perfusion Bioreactor.
- Published in:
- Advanced Healthcare Materials, 2022, v. 11, n. 1, p. 1, doi. 10.1002/adhm.202100684
- By:
- Publication type:
- Article
Severe Skin Lesions in Patients with Glioblastoma Multiforme Treated with a Combination of Cetuximab, Bevacizumab, and Irinotecan.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 1
- By:
- Publication type:
- Article
Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high ACE2 -expressing normal lung.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221133893
- By:
- Publication type:
- Article
Total burden of disease in cancer patients at diagnosis-a Danish nationwide study of multimorbidity and redeemed medication.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Estimating Long-Term Survival Outcomes for Tumor-Agnostic Therapies: Larotrectinib Case Study.
- Published in:
- Oncology, 2022, v. 100, n. 2, p. 124, doi. 10.1159/000519767
- By:
- Publication type:
- Article
Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 1, p. 206, doi. 10.1002/1878-0261.13015
- By:
- Publication type:
- Article
Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility – a prospective, translational study.
- Published in:
- Molecular Oncology, 2020, v. 14, n. 11, p. 2727, doi. 10.1002/1878-0261.12790
- By:
- Publication type:
- Article
Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma.
- Published in:
- Molecular Oncology, 2020, v. 14, n. 5, p. 964, doi. 10.1002/1878-0261.12660
- By:
- Publication type:
- Article
Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients.
- Published in:
- Molecular Oncology, 2016, v. 10, n. 8, p. 1160, doi. 10.1016/j.molonc.2016.05.005
- By:
- Publication type:
- Article
Criteria for site selection in industry-sponsored clinical trials: a survey among decision-makers in biopharmaceutical companies and clinical research organizations.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 2, p. 272, doi. 10.2967/jnumed.115.161703
- By:
- Publication type:
- Article
Precision cancer medicine: Concepts, current practice, and future developments.
- Published in:
- Journal of Internal Medicine, 2023, v. 294, n. 4, p. 455, doi. 10.1111/joim.13709
- By:
- Publication type:
- Article
Supporting Biomarker-Driven Therapies in Oncology: A Genomic Testing Cost Calculator.
- Published in:
- Oncologist, 2023, v. 28, n. 5, p. e242, doi. 10.1093/oncolo/oyad005
- By:
- Publication type:
- Article
Extracranial metastases in glioblastoma—Two case stories.
- Published in:
- Clinical Case Reports, 2019, v. 7, n. 2, p. 289, doi. 10.1002/ccr3.1980
- By:
- Publication type:
- Article
Impact of multimorbidity and polypharmacy on mortality after cancer: a nationwide registry-based cohort study in Denmark 2005–2017.
- Published in:
- Acta Oncologica, 2023, v. 62, n. 12, p. 1653, doi. 10.1080/0284186X.2023.2270145
- By:
- Publication type:
- Article
Extensive genomic analysis in patients with KRAS-mutated solid tumors shows high frequencies of concurrent alterations and potential targets but has limited clinical impact.
- Published in:
- Acta Oncologica, 2022, v. 61, n. 12, p. 1499, doi. 10.1080/0284186X.2022.2156809
- By:
- Publication type:
- Article
Late effects – the new focus of follow-up.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Patients in phase 1 cancer trials: psychological distress and understanding of trial information.
- Published in:
- Acta Oncologica, 2022, v. 61, n. 3, p. 341, doi. 10.1080/0284186X.2021.1993331
- By:
- Publication type:
- Article
A systematic review of targeted agents for non-small cell lung cancer.
- Published in:
- Acta Oncologica, 2018, v. 57, n. 2, p. 176, doi. 10.1080/0284186X.2017.1404634
- By:
- Publication type:
- Article
Development and validation of a prognostic model for recurrent glioblastoma patients treated with bevacizumab and irinotecan.
- Published in:
- Acta Oncologica, 2016, v. 55, n. 4, p. 418, doi. 10.3109/0284186X.2015.1114679
- By:
- Publication type:
- Article
Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study.
- Published in:
- Acta Oncologica, 2014, v. 53, n. 7, p. 939, doi. 10.3109/0284186X.2013.879607
- By:
- Publication type:
- Article
Phase II trial of temsirolimus alone and in combination with irinotecan for KRAS mutant metastatic colorectal cancer: Outcome and results of KRAS mutational analysis in plasma.
- Published in:
- Acta Oncologica, 2013, v. 52, n. 5, p. 963, doi. 10.3109/0284186X.2013.776175
- By:
- Publication type:
- Article
A phase II trial with bevacizumab and irinotecan for patients with primary brain tumors and progression after standard therapy.
- Published in:
- Acta Oncologica, 2012, v. 51, n. 6, p. 797, doi. 10.3109/0284186X.2012.681063
- By:
- Publication type:
- Article
Phase II trial of erlotinib and bevacizumab in patients with advanced upper gastrointestinal cancers.
- Published in:
- Acta Oncologica, 2012, v. 51, n. 2, p. 234, doi. 10.3109/0284186X.2011.619568
- By:
- Publication type:
- Article
A Phase I--II dose escalation study of fixed-dose rate gemcitabine, oxaliplatin and capecitabine every two weeks in advanced cholangiocarcinomas.
- Published in:
- Acta Oncologica, 2011, v. 50, n. 3, p. 448, doi. 10.3109/0284186X.2010.500300
- By:
- Publication type:
- Article
Bevacizumab plus irinotecan in the treatment patients with progressive recurrent malignant brain tumours.
- Published in:
- Acta Oncologica, 2009, v. 48, n. 1, p. 52, doi. 10.1080/02841860802537924
- By:
- Publication type:
- Article
The Use of Longitudinal <sup>18</sup>F-FET MicroPET Imaging to Evaluate Response to Irinotecan in Orthotopic Human Glioblastoma Multiforme Xenografts.
- Published in:
- PLoS ONE, 2014, v. 9, n. 6, p. 1, doi. 10.1371/journal.pone.0100009
- By:
- Publication type:
- Article
Concordance of Mutation Detection in Circulating Tumor DNA in Early Clinical Trials Using Different Blood Collection Protocols.
- Published in:
- Clinical Laboratory, 2017, n. 10, p. 1755, doi. 10.7754/Clin.Lab.2017.170516
- By:
- Publication type:
- Article
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3772, doi. 10.1002/cncr.35036
- By:
- Publication type:
- Article
Phase 1 study of the immunotoxin LMB‐100 in patients with mesothelioma and other solid tumors expressing mesothelin.
- Published in:
- Cancer (0008543X), 2020, v. 126, n. 22, p. 4936, doi. 10.1002/cncr.33145
- By:
- Publication type:
- Article
Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The Neurogenome study: Comprehensive molecular profiling to optimize treatment for Danish glioblastoma patients.
- Published in:
- Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad137
- By:
- Publication type:
- Article
Implementing targeted therapies in the treatment of glioblastoma: Previous shortcomings, future promises, and a multimodal strategy recommendation.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac157
- By:
- Publication type:
- Article
Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2011, v. 38, n. 5, p. 802, doi. 10.1007/s00259-010-1703-y
- By:
- Publication type:
- Article
Characteristics of de novo cancer in liver transplant recipients.
- Published in:
- APMIS, 2023, v. 131, n. 4, p. 135, doi. 10.1111/apm.13296
- By:
- Publication type:
- Article
Personalized oncology: genomic screening in phase 1.
- Published in:
- APMIS, 2014, v. 122, n. 8, p. 723, doi. 10.1111/apm.12293
- By:
- Publication type:
- Article